News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
24/7 Wall St.38d agoneutral
5 High-Yield Dividend Stocks That Pass the Coverage Test (Not Just the Yield Test)Simply Wall St.39d agoneutral
What Does AbbVie (ABBV) Need To Prove After Its Eczema Drug And AI Update?24/7 Wall St.39d agoneutral
BofA Boosts AbbVie and J&J Price Targets on Growth and Pipeline StrengthInvestor's Business Daily40d agobullish
Amazon, Walmart Surplus Auctioneer Climbs Toward A Breakout; Stock Up 45%Simply Wall St.40d agoneutral
FDA Nod For JUVMO Parkinson’s Drug Could Be A Game Changer For AbbVie (ABBV)Simply Wall St.41d agoneutral
Is AbbVie (ABBV) A Bargain After FDA Approval Of JUVMO For Parkinson's?Insider Monkey41d agoneutral
Can AbbVie’s Backing Help ADARx Win Over Biotech IPO Investors at a $1.74 Billion Valuation?